Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
Connor MP, Prathapa N, Frey NV, Gill SI, Hexner EO, Bruno XJ, Lai CE, Loren AW, Luger SM, Matthews AH, McCurdy SR, Perl AE, Porter DL, Zeringue A, Oved JH, Olson TS, Pratz KW, Babushok DV.
Connor MP, et al. Among authors: matthews ah.
Haematologica. 2024 Aug 1;109(8):2732-2737. doi: 10.3324/haematol.2024.285275.
Haematologica. 2024.
PMID: 38634143
Free PMC article.
No abstract available.